CompletedNot Applicable

Hospital Waterbirth Trial to Measure Maternal and Neonatal Outcomes

United States186 participantsStarted 2022-01-17

Plain-language summary

This study aims to explore outcomes of waterbirth in comparison to conventional land birth for low-risk healthy women and neonates in a hospital setting in Milwaukee, WI. This study hypothesizes that women who labor and birth in water will use less pain medication, have a shorter labor, will be more likely to initiate breastfeeding prior to discharge, will not experience more negative outcomes, and will experience greater satisfaction than women who labor and birth on land.

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Able to speak and understand English
✓. Women with a singleton gestation
✓. Able to ambulate with no mobility restrictions (i.e., no difficulty getting from seated to standing)
✓. Less than class III obesity (BMI \<40kg/m squared) at initiation of prenatal care
✓. No active infections such as HIV, Hepatitis B, Hepatitis C, herpes simplex virus outbreak (on prophylaxis acceptable), group B strep positive is acceptable
✓. No pre-existing medical conditions such as: heart disease, uncontrolled asthma, diabetes of any type, chronic hypertension, or other condition that requires continuous observation and/or activity restrictions
✓. No high-risk pregnancy conditions: including preeclampsia, gestational hypertension, preterm gestation, multiple gestation, substance abuse, placental abruption or other unexplained vaginal bleeding, previous cesarean section, suspected fetal macrosomia (\>4500gm) or intrauterine growth restrictions (\<10th percentile), or other condition that requires continuous observation and/or activity restrictions
✓. Greater than 37 weeks and less than 42 completed weeks gestation in vertex presentation

Exclusion criteria

✕. Known need for cesarean section
✕. Participant may be excluded from the study at any time at the discretion of the birth attendant (reason for study exclusion will be documented but will remain in the study group previously selected based on intention to treat).

What they're measuring

Number of Women Using Intravenous Narcotic Analgesia and Epidural Anesthesia

Timeframe: Time of admission to birth of the baby

Trial details

NCT IDNCT05175599

SponsorWake Forest University Health Sciences

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-12-23

Results submitted2026-02-26

View on ClinicalTrials.gov More Pregnancy Related trials